Journal of Pain and Symptom Management
Volume 17, Issue 5 , Pages 369-375 , May 1999

Opioids for Managing Patients with Chronic Pain: Community Pharmacists’ Perspectives and Concerns

  • Brian D Greenwald, MD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, UMDNJ-New Jersey Medical School, and Kessler Institute for Rehabilitation, Inc., West Orange, NJ, USA
    • Corresponding Author InformationBrian D. Greenwald, MD, 531 Clubhouse Court #9, Union, NJ 07083, USA
    • ,
  • Elizabeth J Narcessian, MD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, UMDNJ-New Jersey Medical School, and Kessler Institute for Rehabilitation, Inc., West Orange, NJ, USA

,Accepted 27 November 1998.

References 

  1. Bonica JJ. General considerations of chronic pain. In:  Bonica JJ editors. The management of pain, vol 1. 2nd ed. Philadelphia: Lea and Febiger; 1990;p. 180–183
  2. American Cancer Society. Cancer facts and figures—1998. Atlanta: American Cancer Society.
  3. Foley KM. Treatment of cancer pain. N Engl J Med. 1985;313:84–95
  4. Cleeland CS. The impact of pain on the patient with cancer. Cancer. 1984;54(suppl):2635–2641
  5. Management of cancer pain. U.S. Department of Health and Human Services, AHCPR Guidelines, March 1995.
  6. Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, et al.  Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994;330:592–596
  7. Kanner RM, Portenoy RK. Unavailability of narcotic analgesics for ambulatory cancer patients in New York City. J Pain Symptom Manage. 1986;1:87–89
  8. Holdsworth MT, Raisch DW. Availability of narcotics and pharmacists’ attitudes toward narcotic prescriptions for cancer patients. Ann Pharmacother. 1992;26:321–326
  9. Bressler LR, Geraci MC, Weinberg WJ. Pharmacists’ attitudes and dispensing patterns for opioids in cancer pain management. J Pharm Care Pain Sympt Control. 1995;3:5–18
  10. Weissman DE, Joranson DE, Hopwood MB. Wisconsin physicians’ knowledge and attitudes about opioid analgesic regulation. Wis Med J. 1991;90:671–675
  11. Elliott TE, Murray DM, Elliott BA, Braun B, et al.  Physician knowledge and attitudes about cancer pain management (a survey from the Minnesota Cancer Pain Project). J Pain Symptom Manage. 1995;10:494–504
  12. Elliott TE, Elliott BA. Physician attitudes and beliefs about the use of morphine for cancer pain. J Pain Symptom Manage. 1992;7:141–148
  13. Doucette WR, Mays-Holland T, Memmott H, Lipman AG. Cancer pain management (pharmacist knowledge and practices). J Pain Symptom Manage. 1997;5:17–31
  14. Joranson DE, Cleeland CS, Weissman DE, Gilman AM. Opioids for cancer and noncancer pain (a survey of state board members). Fed Bulletin. 1992;79:15–49
  15. Health and Public Policy Committee American College of Physicians. Drug therapy for severe, chronic pain in terminal illness. Ann Intern Med. 1983;99:870–873
  16. Portenoy RK, Payne R. Acute and chronic pain. In:  Lowinson JH,  Ruiz P,  Millman RB editor. Substance abuse—a comprehensive textbook. 2nd ed. New York: Langrod;; 1992;p. 52
  17. Walsh TD. Oral morphine in chronic pain. Pain. 1984;18:1–11
  18. Kanner RM, Foley KM. Pattern of narcotic drug use in cancer pain clinic. Ann NY Acad Sci. 1981;362:161–173
  19. Bressler LR, Geraci MC, Schatz BS. Misperceptions and inadequate pain management in cancer patients. DICP. 1991;25:1225–1230
  20. Medina JL, Diamond S. Drug dependency in patients with chronic headache. Headache. 1977;17:12–14
  21. Perry S, Heidrich G. Management of pain during debridement (a survey of US burn units). Pain. 1982;13:267–280
  22. Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med. 1980;302:123
  23. Berina LF, Guernsey BG, Hokason JA, Doutre WH. Physician perception of a triplicate law. Am J Hosp Pharm. 1985;42:857–859

PII: S0885-3924(99)00010-X

Journal of Pain and Symptom Management
Volume 17, Issue 5 , Pages 369-375 , May 1999

Article Tools